Topic: Aseptic Technique

1 chapters across the catalog

A whistleblower recently exposed egregious safety violations at Eli Lilly manufacturing facilities, including improper sanitization and the destruction of evidence before FDA inspections. While Reuters covered the story, major media outlets largely ignored the findings. Brigham Bueller argues that these revelations challenge the narrative that FDA-approved pharmaceutical products are inherently safer than those from compounding pharmacies.